2 Drug Stocks at New Lows

The healthcare sector is also doing well today

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
Midday Market Check
 
 

5/21/2019

One Pot Stock Set to Dominate


Marijuana has become an all-out race to profitability, many are light years away, but a select few have spent years building and acquiring, most of the names you know.

It's a name you likely don't know that could yield life changing returns...and you can get that name here.

unit
Dow Rises Sharply as Tech Rebounds

By Josh Selway

Share On

U.S. stocks are pushing higher today thanks to the more lenient stance taken against Huawei by the Trump administration. The Dow is trading well into triple-digit territory, and gains from the tech and healthcare sectors are helping the S&P 500 Index (SPX) and Nasdaq Composite (IXIC) rise, as well. On the data front, traders were greeted with another drop in existing U.S. home sales for April.

Continue reading for more on today's market, including: 

>> Continue reading...
LATEST HEADLINES

>> BofA-Merrill Lynch: Buy This Shoe Stock Before Earnings
The brokerage firm thinks the retailer can rally another 26%
>> Analytics Stock Ripe for Options Bulls
The stock recently bounced from double-barreled support
>> 2 Drug Stocks Getting Crushed Today
Both drug stocks are heavily shorted, too
>> SNAP Stock Pops on C-Suite Shake Up
Shorts have ramped up attention on SNAP recently
>> Glaucoma Drug's Flop Has OCUL Stock Spiraling
Ocular Therapeutix hit a record low out of the gate
ADVERTISEMENT

The Search for The Perfect Pot Stock is Over


2019 is off to crazy start for many marijuana stocks, some reaching all-time highs. But at 250 times earnings where is the upside? The key is to play pot stocks like Buffett, find undervalued companies with great long term earning potential, like this gem we've uncovered.

To ensure delivery of Schaeffer's Midday Market Check, add us to your contacts! For more information, please visit this link for further instructions.

This email was sent to phanhoa1821960.trader@blogger.com because you are a registered subscriber to Schaeffer's Midday Market Check or have signed up to receive emails from www.schaeffersresearch.com. Don't want to receive Schaeffer's Midday Market Check? You can unsubscribe here.

For more information about our privacy practices, please review our Privacy Policy or our Terms & Conditions.

Have a question, comment or concern? We’ll respond quickest if you call (800) 448-2080, email, or write to:

Schaeffer's Midday Market Check

No comments:

Post a Comment